South Korea-based International Vaccine Institute (IVI) has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
Japan's Takeda partners with India's Biological E. to boost dengue vaccine production
Enforcement Report - Week of January 31, 2024
Corbevax vaccine gets WHO Emergency Use Listing authorisation
Enforcement Report - Week of September 20, 2023
Bharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses
Biological E (BE) said it is actively exploring the option of hiving off its non-vaccine business into a separate entity and raising funds by selling equity stakes to investors.
BE's pediatric pneumonia jab gets CDSCO expert panel approval
Subject expert committee (SEC) of the drug regulator has reviewed and approved phase-3 infants clinical trial data of Biological E's paediatric vaccine against streptococcus pneumonia and recommended its manufacture, the Hyderabad-based vaccine maker said on Thursday.
Pune-based Serum Institute of India (SII), Reliance Life Sciences, Dr Reddy's Laboratories, Biological E and two state-owned units - Mumbai-based Haffkine Ins ..